Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Nicotine Dependence

In brief

Randomized trial to evaluate whether zonisamide can enhance varenicline-induced smoking cessation.

Key facts

Study ID
NCT01685996
Run by
Johns Hopkins University
People needed
74
Starts
2012-09-01
Expected to finish
2014-05-01
Last updated by the study team
2018-01-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.